DRUGS

Sevoflurane

ndungukelvin1@gmail.com2023-03-23T15:16:22+03:00

General anesthesia: 0-1 month neonate: 3.3% in oxygen 1-6 [...]

Sevofluranendungukelvin1@gmail.com2023-03-23T15:16:22+03:00

ndungukelvin1@gmail.com2023-03-24T16:09:46+03:00

For the control of serum phosphorus in patients with [...]

Sevelamerndungukelvin1@gmail.com2023-03-24T16:09:46+03:00

ndungukelvin1@gmail.com2023-03-24T16:12:18+03:00

Major depressive disorder: PO 50mg OD May be increased [...]

Sertralinendungukelvin1@gmail.com2023-03-24T16:12:18+03:00

ndungukelvin1@gmail.com2023-03-24T16:12:00+03:00

Interdigital tinea pedis: Adults and ≥12 years: Apply BD [...]

Sertaconazole topicalndungukelvin1@gmail.com2023-03-24T16:12:00+03:00

ndungukelvin1@gmail.com2023-03-24T16:10:33+03:00

Constipation (max 1 week use): Adults & ≥12 years: [...]

Senna (Sennosides)ndungukelvin1@gmail.com2023-03-24T16:10:33+03:00

ndungukelvin1@gmail.com2023-03-24T15:55:18+03:00

Adjunct treatment in Parkisonism disease: PO 5mg at breakfast [...]

Selegilinendungukelvin1@gmail.com2023-03-24T15:55:18+03:00

ndungukelvin1@gmail.com2023-03-24T15:54:46+03:00

Type II DM: PO 1-2 tabs OD Tablet: [...]

Saxagliptin/ Metforminndungukelvin1@gmail.com2023-03-24T15:54:46+03:00

ndungukelvin1@gmail.com2023-03-24T15:55:56+03:00

Type 2 DM: PO 2.5-5mg OD Max 5mg [...]

Saxagliptinndungukelvin1@gmail.com2023-03-24T15:55:56+03:00

ndungukelvin1@gmail.com2023-03-24T15:57:29+03:00

Reduce risk of cardiovascular death and hospitalization in chronic [...]

Sacubitril/ Valsartanndungukelvin1@gmail.com2023-03-24T15:57:29+03:00

ndungukelvin1@gmail.com2023-03-24T15:59:38+03:00

Myelofibrosis (intermediate or high-risk): Baseline Pt >200,000: Initially PO [...]

Ruxolitinibndungukelvin1@gmail.com2023-03-24T15:59:38+03:00